Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules

Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules

With the emergence and rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants, escaping vaccine-induced immunity is a concern. Three vaccination schedules, homologous or heterologous, have been initially applied due to an insufficient supply of vaccin...

Full description

Bibliographic Details
Main Authors: Ju-yeon Choi, Young Jae Lee, Jae-Hoon Ko, Su-Hwan Kim, Hye-Jin Kim, Hye Won Lee, Hyeonji Jeong, Tae-Yong Kim, Yeong Gyeong Jang, Hyo-jeong Hong, Min-Seong Kim, Sang Eun Lee, Yong Guan Kim, Eun Joo Chung, Heeji Lim, Sundong Jang, Kwangwook Kim, Sung Soon Kim, Jin Young Ahn, Jun Yong Choi, Yong Chan Kim, Yoon Soo Park, Kyong Ran Peck, Byoungguk Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
neutralizing activity
Omicron variant
Delta variant
SARS-CoV-2
vaccine
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.948014/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2022.948014/full

Similar Items